SSA
PHVS icon

Schonfeld Strategic Advisors’s Pharvaris PHVS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,400
Closed -$348K – 2314
2023
Q4 		$348K Buy
12,400
+500
+4% +$10.1K ﹤0.01% 1392
2023
Q3 		$248K Buy
11,900
+300
+3% +$5.53K ﹤0.01% 1360
2023
Q2 		$176K Buy
11,600
+100
+0.9% +$967 ﹤0.01% 1607
2023
Q1 		$92.6K Sell
11,500
-4,800
-29% -$42.3K ﹤0.01% 1705
2022
Q4 		$183K Buy
+16,300
New +$85.7K ﹤0.01% 2018

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Schonfeld Strategic Advisors's PHVS Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of Pharvaris (PHVS) in Q1 2024, closing a stake of 12,400 shares — an estimated $348K sold.

Schonfeld Strategic Advisors first reported a position in PHVS in Q4 2022 and held it in 5 quarters. The position peaked at $348K in Q4 2023. 35 funds tracked by Wall St. Rank hold PHVS as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining Pharvaris position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 12,400 Pharvaris shares in Q1 2024, an estimated $348K.
  • Schonfeld Strategic Advisors first reported a position in Pharvaris in Q4 2022 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's Pharvaris position peaked at $348K in Q4 2023.
  • 35 funds tracked by Wall St. Rank held Pharvaris as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.